03 novembre 2017 Radioterapia

RayStation selected for CYCLHAD Hadrontherapy Center, France (Archade program)

Following a competitive tender process, RayStation has been chosen as the treatment planning system for the CYCLHAD Hadrontherapy Center, located in Caen, France. The center is due to open in 2018 and will be France’s third clinical proton therapy center.

CYCLHAD will deliver proton therapy treatments via IBA’s ProteusOne compact system, with the first patient treatment scheduled to take place in June. The center is owned, operated and managed by SAS CYCLHAD, and treatment will be conducted by the medical teams of Centre François Baclesse, a comprehensive cancer center located in Caen.

A further phase of expansion is planned for the center, including the installation of the NHa C400 cyclotron system to enable research with carbon ions.

The RayStation purchase includes the modules for pencil beam scanning, adaptive therapy, biology and patient modeling.

Philippe Lagalle, CEO of SAS CYCLHAD, says: “As a pioneering center, we need partners who can deliver when it comes to advanced techniques. RaySearch is a world leader in treatment planning for proton therapy and has proven expertise in supporting IBA systems. RayStation’s power and innovative capabilities will help us to ensure world-class treatment and research. We also plan to evaluate the possibilities of the forthcoming RayCare* oncology information system.”

Johan Löf, CEO of RaySearch, says: “We are proud to support one of France’s first proton centers. Proton therapy is an important focus area for RaySearch. We have a large market share and our success in this area continues to grow. RaySearch has a strong strategic collaboration with IBA, which builds on our joint commitment to taking proton therapy to new levels.”

 

About the ARCHADE program
ARCHADE (Advanced Resource Centre for Hadrontherapy in Europe) is a collaborative initiative to create a European center dedicated to hadron therapy research, development and clinical treatment. The CYCLHAD Hadrontherapy Center, Located in Caen, France, will carry out multidisciplinary research and treat up to 345 patients per year using proton therapy.

News

03/07/2018 News

RaySearch and Eckert & Ziegler BEBIG enter into partnership regarding brachytherapy

RaySearch and Eckert & Ziegler BEBIG, a leading European supplier of brachytherapy products, have signed a partnership agreement. Both the RayStation® treatment planning system and the RayCare* oncology infor [...]

02/07/2018 News

DE.TEC.TOR entra nel gruppo TA Technologic ed Euroimaging

Abbiamo il piacere di comunicare che il 28 Giugno 2018 è stato siglato un accordo per l'incorporazione della società DE.TEC.TOR., leader mondiale nella ricerca e sviluppo di rivelato [...]

22/06/2018 News

Primo paziente in Italia trattato con il sistema Radixact™

Tecnologie Avanzate è lieta di annunciare che oggi è stato trattato il primo paziente in Italia con il nuovo sistema Radixact™  di Accuray, presso il nuovissimo sito dello IOV che si trova&n [...]

Eventi

20gen2017 | Eventi

RayCare Symposium, Roma 26 gennaio 2017

Tecnologie Avanzate è lieta di comunicare che il 26 gennaio organizza a Roma il primo RayCare Symposium, un incontro destinato a presentare in [...]

17set2018 | Radioprotezione e QA

Scuola AIFM di Radioprotezione in ambito sanitario, Roma 17-21 settembre 2018

Tecnologie Avanzate sarà sponsor della "Scuola AIFM di Radioprotezione in ambito sanitario", che avrà luogo a Roma dal 17 al 21 settembr [...]

Video gallery